FFUP| 1 Bolsa de Investigação| Projeto CHARLIE|BOLS-FFUP-26-22

Description

Offer Description: CALL FOR APPLICATIONS FOR 1 (ONE) RESEARCH GRANT (BI), AS PART OF THE “CHARLIE” PROJECT—CARCINOGENIC POTENTIAL OF HEATED TOBACCO PRODUCTS AND ELECTRONIC CIGARETTES IN THE DEVELOPMENT OF BLADDER CANCER (REF. 2024.13406. PEX), CURRENTLY UNDERWAY AT THE UNIT OF APPLIED BIOMOLECULAR SCIENCES/SCHOOL OF PHARMACY OF THE UNIVERSITY OF PORTO (UCIBIO/FFUP) - BOLS-FFUP-26-22. By order of the Assistant Dean of the Faculty of Pharmacy at the University of Porto (FFUP), Professor Dr. Susana Isabel Pereira Casal Vicente, dated October 2, 2026, it is hereby announced that this call for applications is now open for the award of 1 (one) Research Fellowship (BI) to a student enrolled in a doctoral program or a master’s student enrolled in a non-degree-granting program, to carry out R&D activities within the scope of the “CHARLIE—Carcinogenic potential of heated tobacco products and e-cigarettes in the development of bladder cancer” project (Ref. 2024.13406. PEX), funded by the Foundation for Science and Technology, currently underway in the Department of Biological Sciences at the Faculty of Pharmacy of the University of Porto. Applicable Legislation and Regulations The selection process and the awarding of the fellowship are governed by the provisions set forth in the Research Fellowship Statute (EBI), approved by Law No. 40/2004 of August 18, as currently in force, published by Decree-Law No. 65/2024 of October 1; the University of Porto Research Fellowship Regulations, approved by Regulation No. 184/2021, of March 3, amended and republished by Regulation No. 582/2026, of May 19 (hereinafter referred to as the “Regulations”); Regulations on Research Grants of the Foundation for Science and Technology (FCT), I.P., approved by Regulation No. 950/2019, of December 16, in its current version (applied subsidiarily); Legal Framework for the Recognition of Academic Degrees and Higher Education Diplomas Awarded by Foreign Higher Education Institutions, approved by Decree-Law No. 66/2018, of August 16; Code of Administrative Procedure (CPA), approved by Decree-Law No. 4/2015, of January 7; and other applicable regulations. I – Description and Conditions of the Fellowship 1. Scientific Field(s): Biomedical Sciences, Cellular and Molecular Biology, Toxicology. 2. Host Institution and Location for Carrying Out the Work Plan: The work plan will be carried out at the UCIBIO-Porto Unit, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, and/or other locations necessary for its execution. 3. Amount of the Monthly Living Allowance: 3.1. The amount of the monthly living allowance for the fellowship is €1,359.64, as specified in Annex I of the Regulations. 3.2. Payment will be made by the Faculty of Pharmacy of the University of Porto via bank transfer. In addition to this stipend, the scholarship recipient will be covered by personal accident insurance. 3.3. The scholarship recipient may enroll in Voluntary Social Security (valid for scholarship contracts of six months or longer); this is optional (not mandatory), and the reimbursement corresponds to the first bracket of the contribution base. 4. Duration of the fellowship: The BI fellowship will last for 6 months on a full-time basis and may be renewed for an additional 6 months, following a positive evaluation, up to the end of the work plan’s implementation period or the funding period; under no circumstances may the fellowship last longer than one year when it has been awarded to a bachelor’s degree holder enrolled in a program of study that does not lead to an academic degree, pursuant to Article 10(3) of the Regulations. 5. Work Plan: 5.1. The main tasks to be performed under the fellowship will be: a) Assessment of the viability and cellular morphology of bladder cells exposed to urinary chemical markers associated with the use of heated tobacco products and e-cigarettes, using the MTT assay and bright-field/phase-contrast and fluorescence microscopy; b) Asses

Sectors

Source

Source: euraxess.ec.europa.eu